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Developmental Control of Blood Cell Migration
by the Drosophila VEGF Pathway
Blood cells (hemocytes) in Drosophila also migrate
extensively during development (Tepass et al., 1994).
They originate in the head mesoderm, and over a 7 hr
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1Howard Hughes Medical Institute period in midembryogenesis they migrate along specific
pathways to disperse throughout the body, where theyDepartment of Biochemistry
Stanford University function as immune and interstitial cells. Like vertebrate
monocytes and macrophages, insect hemocytes pha-Stanford, California 94305
2 Genetics Department gocytose or encapsulate foreign material and apoptotic
cells (Hoffmann et al., 1999). This is important duringExelixis Incorporated
170 Harbor Way development because cell death is widespread, and as
hemocytes disperse through the embryo they recognizeSouth San Francisco, California 94083
and remove cell remnants (Abrams et al., 1993). Hemo-
cytes also produce many extracellular matrix molecules,
including collagen IV and laminin, that compose theSummary
basement membrane surrounding internal organs (Fess-
ler and Fessler, 1989).We show that a vascular endothelial growth factor
Although there has been progress in understanding(VEGF) pathway controls embryonic migrations of
the genetic control of blood cell differentiation in Dro-blood cells (hemocytes) in Drosophila. The VEGF re-
sophila (Lebestky et al., 2000) and the ability of bloodceptor homolog is expressed in hemocytes, and three
cells to recognize and engulf dying cells (Franc et al.,VEGF homologs are expressed along hemocyte migra-
1999), little is known of the genetic and molecular mech-tion routes. A receptor mutation arrests progression
anisms controlling their developmental migrations. It isof blood cell movement. Mutations in Vegf17E or
also unclear how developmental migrations are coordi-Vegf27Cb have no effect, but simultaneous inactiva-
nated with hemocyte homing toward dying cells alongtion of all three Vegf genes phenocopied the receptor
the migration pathway.mutant, and ectopic expression of Vegf27Cb redi-
Here, we genetically characterize four Drosophilarected migration. Genetic experiments indicate that
genes encoding homologs of mammalian VEGF andthe VEGF pathway functions independently of path-
VEGF receptor (VEGFR), a family of receptor tyrosineways governing hemocyte homing on apoptotic cells.
kinases (RTKs) and their ligands that have been promi-The results suggest that the Drosophila VEGF pathway
nently implicated in blood vessel and lymphatic devel-guides developmental migrations of blood cells, and
opment (Clauss, 2000). Recently, the Drosophila VEGFRwe speculate that the ancestral function of VEGF path-
and one of the ligands were implicated in border cellways was to guide blood cell movement.
migration in the ovary (Duchek et al., 2001). We show
that Vegfr is also expressed in developing blood cellsIntroduction
(see also Heino et al., 2001), and that a Vegfr mutation
disrupts their migration. We also show that the threeAmong the most remarkable examples of cell migration
Vegf genes are expressed along many hemocyte migra-are the journeys through the body that blood cells un-
tory paths, and they are redundantly required for migra-dergo during their development into mature leukocytes
tion. Ectopic expression of a ligand redirects migrationand erythrocytes. In mammals, hematopoietic stem cells
to a new position. We provide evidence that VEGF con-are thought to originate in the aorta-gonad-mesoneph-
trol of blood cell migration is independent of the physio-ros region and move through the vascular system before
logical pathways that target hemocytes to dying cells.entering the fetal liver and bone marrow to establish
The results indicate that VEGF signaling controls devel-these hematopoietic organs (Medvinsky and Dzierzak,
opmental migrations of hemocytes, and we speculate1996). Later, T cell precursors exit these organs and
that the function of the ancestral VEGF pathway was tomigrate to the thymus where they differentiate into ma-
guide blood cell movement.ture T cells that are exported to the periphery to carry
out immune functions (Rodewald, 1995). Little is known
about how these complex migrations are controlled. 1- Results
integrin is required to seed the fetal liver (Hirsch et al.,
1996), and in vitro studies have shown that the thymus Characterization of a Drosophila Gene Encoding
a VEGFR Homologcan serve as a chemoattractant source for hematopoi-
etic precursors (Champion et al., 1986). However, the BLAST sequence homology searches of the Drosophila
genome and cDNA sequences identified a single genemolecules that control these and other developmental
blood cell migrations in vivo have not been definitively (CG8222, cytological region 29A) that encodes a protein
with substantial similarity to mammalian VEGFRs. Weestablished.
call it Vegfr, but it is also known as Pvr (Duchek et al.,
2001). Figure 1A shows the structure of the gene and3 Correspondence: krasnow@cmgm.stanford.edu
three mRNA splice forms deduced from multiple over-4 Present address: Institute of Molecular Biology, University of Ore-
gon, Eugene, Oregon 97403. lapping and three full cDNA sequences.
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Figure 1. Vegfr Locus and Products
(A) Exon-intron structure (top line); exons
(thick bars) are numbered. Position and 5 to
3 orientation (arrows) of piggyBac[w] (PB)
transposon inserts are shown. Sizes of in-
trons not drawn to scale are indicated. Struc-
tures of three Vegfr mRNA splice forms (A, B,
and C, each5.7 kb) are shown below. Splice
variants utilize alternate 5 splice sites in the
first and fourth introns. A also uses a different
3 splice site in intron 12. Open boxes, coding
regions; striped box, transmembrane domain
exon.
(B) Comparison of Drosophila VEGFR iso-
forms and human VEGFRs and PDGFR. Black
boxes, six extra amino acids in VEGFR-A and
35 extra amino acids in VEGFR-B due to dif-
ferential splicing. VEGFR-C is a truncated
protein due to differential splicing, with nine
novel residues at C terminus. Numbers show
sequence identity to Drosophila VEGFR-A in
Ig-like loops (Ig), juxtamembrane domain (jm),
and split tyrosine kinase domain (tk). Dia-
mond, signal peptide.
The splice forms encode distinct proteins (Figure 1B). Vegfr Is Expressed in Developing Blood Cells
The embryonic expression pattern of Vegfr was deter-Isoforms A (147 kDa) and B (150 kDa) are predicted
Type I transmembrane proteins with an N-terminal signal mined by RNA in situ hybridization (Figure 2). Transcript
was first detected in two bilaterally symmetric clusterspeptide, seven Ig-like repeats, a transmembrane do-
main, and a split tyrosine kinase domain (Figure 1B). of mesodermal cells in the head region of early stage 8
embryos (4 hr after egg lay [AEL]; Figure 2A). DuringThe tyrosine kinase domain is most similar to those of
vertebrate VEGFR1 (Flt-1) and VEGFR2 (KDR/FLK-1) but the next 11 hr of development, these cells undergo a
stereotyped series of migrations that disperse themalso shows substantial similarity to other members of
the split RTK family including PDGFR-. There is addi- throughout the embryo. The cells migrate out from the
clusters in three directions (Figures 2B and 2C). Sometional similarity to the vertebrate receptors in the juxta
membrane region and Ig-like repeats. Like vertebrate cells migrate anteriorly into the clypeolabrum, while oth-
ers migrate ventrally toward the gnathal buds (FiguresVEGFRs, the ectodomain of the Drosophila proteins
contains seven Ig-like repeats, which distinguishes them 2C and 2J). The majority migrate posteriorly toward the
caudal end (tail) of the germband-extended embryo,from other members of the split RTK family, such as
PDGFRs which contain only five (Fantl et al., 1993). Iso- coursing between the amnioserosa and the yolk sac to
reach its posterior margin (Figures 2C and 2K). Onceform B differs from A by one amino acid in place of
seven between the second and third Ig-like repeats and cells move past the posterior margin into the tail (Figure
2D), they surround the hindgut opening and migrateby 35 additional amino acids in the kinase insert domain.
Isoform C (25 kDa) is a truncated protein consisting of along the ventral midline (Figure 2H). By the beginning
of stage 12 (9 hr AEL), these migrations produce twothe signal peptide and the first two Ig-like repeats. It
may be able to bind ligand, because only the second Ig- populations of cells, one in the anterior scattered around
their site of origin, the other in the posterior clusteredlike repeat of vertebrate VEGFR1 is essential for ligand
binding (Davis-Smyth et al., 1996). around the hindgut and ventral midline (Figure 2E). Dur-
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ing stages 12–14 (10–12 hr AEL), both populations
migrate toward the middle of the embryo along three
major routes (Figures 2E and 2F): (1) the ventral midline
(dorsal and ventral to the developing nerve cord), (2) the
gut, and (3) the dorsal epidermis. Later, cells leave these
paths and become uniformly distributed (Figure 2G).
The positions and movements of most Vegfr-express-
ing cells resemble those of developing blood cells (Te-
pass et al., 1994). Indeed, the Vegfr expression pattern
was difficult to distinguish from that of the blood cell
(plasmatocyte) markers Peroxidasin (Nelson et al., 1994)
and Croquemort (Franc et al., 1996) except that Vegfr
turned on 2 hr earlier (data not shown). (We do not
know if Vegfr is expressed in crystal cells, a minor sub-
population of hemocytes.) To confirm that Vegfr-
expressing cells are hemocytes, we examined serpentAS
mutants (Rehorn et al., 1996), which lack blood cells.
All Vegfr-expressing cells were absent in srpAS embryos
(Figure 2I), except those noted below. In situ hybridiza-
tion of fixed larvae indicated that larval blood cells also
express Vegfr (data not shown). Thus, Vegfr is expressed
in most or all embryonic and larval blood cells through-
out their development.
Three groups of Vegfr-expressing cells were not elimi-
nated in srpAS mutants: (1) tracheal cells from stages
11–13 (Figures 2D and 2E); (2) a small group of cells
near each tracheal visceral branch (see below); and (3)
a small group of ventral midline cells in each segment,
possibly midline glia.
Disruption of Blood Cell Migration
in Vegfr Mutants
A large-scale mutagenesis was carried out by mobilizing
a piggyBac[w] transposable element (see Experimental
Procedures; S. Thibault et al., personal communication).
Inverse PCR and DNA sequencing of piggyBac[w] in-
sertion sites identified three lines with insertions in Vegfr
(Figure 1A). Vegfrc2195 is a homozygous lethal insertion
located within the small (67 base) 11th intron (Figure
Figure 2. Vegfr mRNA Expression 1A). RNA in situ hybridization demonstrated that Vegfr
In situ hybridization showing distribution of Vegfr mRNA at embry- transcript is undetectable in Vegfrc2195 embryos (data not
onic stages indicated in wild-type (A–H, J, and K) and srpAS mutant shown), and genetic studies indicate it is an amorphic
(I). Punctate staining is migrating blood cells, which are schematized allele (see below).in right panels; schematics include blood cells in other focal planes.
Vegfrc2195 mutants displayed a striking defect in hemo-In this and other figures, dorsal is up and anterior left unless other-
cyte migration (Figure 3). Formation of hemocytes andwise noted.
(A) Expression begins at early stage 8 in head mesoderm. Bar for their initial migrations were normal, as judged by staining
(A)–(I) is 40 m. of Croquemort (CRQ) and Peroxidasin (PXN). By stage
(B) Cells migrate out in three directions (arrows). 11, posteriorly directed hemocytes reached the caudal
(C) By early stage 11 (st.11a), cells have moved anteriorly into clyp- margin normally (Figure 3B). However, unlike Vegfreolabrum (cl; see [J]), ventrally into gnathal buds (gb, see [J]), and
blood cells, which rapidly enter the tail (Figures 3A andposteriorly toward tail (arrowhead, see [K]). Dotted line, tail margin.
3C), blood cells in mutant embryos never entered the(D) By late stage 11 (st.11b), posteriorly directed cells have entered
tail. Expression is also detected in tracheal cells (tr; not shown in region, instead accumulating at the caudal margin (Fig-
schematics). ures 3B and 3D). By stage 13, wild-type hemocytes are
(E) The migrations produce hemocytes in anterior (ant) and posterior dispersed throughout the embryo (Figure 3E), whereas
(post) ends of embryo. Subsequent migrations (arrows) toward mid- mutant hemocytes were clumped together in aggre-dle of embryo occur along (1) ventral nerve cord, (2) gut, and (3)
gates concentrated in the anterior (Figure 3F). The mu-dorsal epidermis.
(F) Vegfr-expressing cells have reached central region. From there,
cells spread as shown by arrows.
(G) Vegfr-expressing cells are distributed throughout the embryo.
(H) Stage 11b (dorsal view). Vegfr-expressing cells in tail are clus- eliminated, but tracheal expression (circled) is retained.
tered around hindgut (hg) and along ventral midline (vm). Tracheal (J) Close-up and deeper focal plane of C showing blood cells in
cells expressing Vegfr are also seen. Schematic depicts only blood clypeolabrum and gnathal buds. Bar for (J) and (K) is 20 m.
cells in tail. (K) Close-up of C showing blood cells (arrowhead) arriving at tail.
(I) srpAS embryo at same stage. Vegfr expression in blood cells is Diffuse dark areas in embryos are contrast from underlying tissues.
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tant blood cells continued to express CRQ and PXN,
suggesting that hemocyte differentiation was grossly
intact (Figure 3 and data not shown). Interestingly, CRQ
staining was stronger than in wild-type, even in isolated
blood cells (arrowheads in Figures 3G and 3H), implying
their phagocytic function was activated (see below).
Aside from the hemocyte defects, the mutant embryos
appeared normal, and no defects were detected in the
CNS, muscles, and tracheal system after staining with
tissue-specific markers (data not shown).
The severity of the hemocyte phenotype of Vegfrc2195
homozygotes was the same as that of Vegfrc2195 hemizy-
gotes and homozygous deficiency embryos (Figures 3I
and 3J), implying that Vegfrc2195 is an amorphic allele.
Vegfrc2859, a lethal piggyBac[w] insertion in the first in-
tron, and Vegfrc3211, a homozygous viable insertion in
the 3 noncoding region, did not exhibit the hemocyte
phenotype. However, the disruption of hemocyte migra-
tion clearly reflects a requirement for Vegfr function, as
the migration defect was also seen when endogenous
Vegfr transcripts were depleted by RNAi (see below).
We conclude that inactivation of the Vegfr gene blocks
progression of blood cell movement; hence, we propose
the gene name stasis (stai, pronounced “stay”), which
means slowing or stopping.
The RAS-MAPK pathway is activated by signaling
through VEGFRs and other RTKs (Seger and Krebs,
1995), so we investigated whether RAS-MAPK was in-
volved in hemocyte migration. Immunostaining with a
diphospho-MAPK antiserum (-dpERK) showed that
MAPK was activated in migrating hemocytes (Figure
3N). MAPK activation was greatly reduced in Vegfr mu-
tants (Figure 3O), and it was increased by ectopic ex-
pression of a VEGF ligand (Figure 3P). It was not possible
to test the effect of complete loss of RAS-MAPK path-
way activity in embryonic hemocytes, because pathway
components are both maternally and zygotically re-
quired and expressed. Zygotic loss of function muta-
tions in any of the three genes encoding adaptor pro-
teins (drk, dshc) or a RAS exchange factor (sos) had no
effect on hemocyte migration (data not shown). How-Figure 3. Vegfr Mutant Effects on Blood Cell Migration and MAPK
ever, expression of a dominant-negative RAS proteinActivation
(DRAS1N17) in hemocytes caused an early migration ar-Vegfr (Vegfrc2195/) (A, C, E, and G) and homozygous Vegfrc2195 (B,
rest similar to that seen in the Vegfr mutant (FiguresD, F, and H) embryos at stages indicated, stained for hemocyte
3K–3M), implicating RAS in the process.marker CRQ. Punctate staining is blood cells; diffuse staining is
nonspecific background.
(A) By late stage 11, Vegfr hemocytes have passed the tail margin Characterization of Drosophila Genes Encoding
(dotted line) and entered the tail (bracket). VEGF Homologs
(B) In mutant, none have done so (asterisk). Instead, hemocytes
BLAST searches identified three genes encoding pro-(arrowhead) accumulate anterior to tail.
teins with sequence similarity to vertebrate VEGFs. Fig-(C) Vegfr hemocytes continue to enter and migrate through tail.
(D) In mutant, hemocytes accumulate at margin but do not enter
tail.
(E) Vegfr hemocytes are distributed along their migratory paths (M) Dras1N17/gcm-Gal4 embryo. Hemocytes expressing dominant-
throughout embryo. negative RAS also fail to enter tail.
(F) Hemocytes in mutant are located almost exclusively in clumps (N–P) MAPK activation in stage 13 hemocytes shown by double
(arrowheads) in anterior (bracket). labeling with anti-dpERK (green) and anti-CRQ (red). Groups of he-
(G) Vegfr hemocytes are uniformly distributed. mocytes are outlined.
(H) Hemocytes in mutant form clumps in anterior. Isolated hemo- (N) Wild-type. dpERK staining is seen although not uniformly in all
cytes (arrowhead) stain more intensely for CRQ than in wild-type hemocytes.
(arrowhead in [G]). (O) Vegfrc2195 homozygote. dpERK staining is greatly reduced. In
(I and J) Stage 17 Vegfrc2195 hemizygote (I) and homozygous defi- other embryos, staining ranged from undetectable to moderately
ciency embryo (J) (dorsal view) show similar defects as Vegfrc2195 reduced.
homozygotes. (P) btl-Gal4/XP d2444 embryo overexpressing Vegf27Cb; dpERK
(K) Close-up dorsal view of tail of stage 12 wild-type embryo. Migrating staining is increased and more uniform in hemocytes. The signal to
hemocytes have passed tail margin (white dots) and entered tail. right of hemocytes in CRQ channel is nonspecific gut staining. Bars
(L) Vegfrc2195 mutant. Hemocytes fail to enter tail. in M (for K–M), 20 m; N (for N) and P (for O and P), 10 m.
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Figure 4. Structure and Products of Drosophila Vegf Genes
(A) Vegf loci at cytological position 27C. Exons, thick boxes; introns and intergenic region, thin line. Transposon insertion sites (triangles) and
orientations (arrows) are indicated. cDNA structures are shown below line. Coding sequences, open boxes; striped region, PDGF domain.
Sizes of introns and intergenic region not drawn to scale are indicated.
(B) Vegf17E locus. Sequences deleted in Vegf17Eex3.6 are indicated; dotted extensions indicate range of uncertainty in deletion endpoints.
Vegf17E splice forms A and B use alternative 3 splice sites in first intron. Coding region of A begins at an upstream AUG and encodes 11
extra N-terminal residues.
(C) Schematics of Drosophila and human VEGF family members. Dotted box, signal peptide. Diagonal stripes, PDGF domain. Gray fill, heparin
binding domain. Vertical stripes, cysteine-rich domain. Cysteine residues in hVEGF-C (but not Drosophila VEGFs) are predicted to form a ring
domain.
(D) Sequences of PDGF domain of Drosophila and human VEGF family members. Gray boxes, identical residues. Asterisks, conserved cysteines
required for inter- and intramolecular disulfide bonds in VEGF family members. Box, PDGF signature motif.
(E) Dendrogram showing sequence relatedness of Drosophila and human VEGFs. Branch lengths represent the mean number of differences
per residue along each branch.
ures 4A and 4B show the gene structures deduced from found in human VEGF-A and VEGF-B (Ferrara and Hen-
zel, 1989). VEGF17E is slightly more similar to vertebratepartial cDNA sequences and complete sequences of full
cDNA clones. Vegf27Ca (CG13781/13782; also referred VEGFs than to PDGF, whereas VEGF27Ca and VEGF27Cb
are equally similar to both (Figure 4E).to as Pvf3) and Vegf27Cb (CG13780; also referred to as
Pvf2) are adjacent genes at cytological position 27C
(Figure 4A). The genes are tandemly arrayed, separated Vegf Genes Are Expressed along Blood Cell
Migration Pathwaysby 16 kb. Their close proximity, sequence similarity,
and nearly identical expression patterns (see below) Embryonic expression patterns of Vegf genes were ana-
lyzed by RNA in situ hybridization. The genes were ex-suggest they were generated by a recent gene duplica-
tion. The VEGF homolog at cytological position 17E pressed in dynamic spatial and temporal patterns that
line many of the migratory paths of developing blood(Vegf17E; CG7103; also referred to as Pvf1) produces
two splice variants (A and B) that differ by 11 N-terminal cells. Vegf17E began to be expressed at the end of stage
10 in an ectodermal patch at the caudal margin of theresidues.
All the Drosophila VEGF proteins have a predicted germband (Figures 5A and 5R) where blood cells enter
the tail. It was also expressed in the developing tracheasignal peptide and central domain common to VEGF/
PDGF superfamily members (Figures 4C and 4D). All and salivary glands (Figures 5A and 5I). General tracheal
expression persisted through stage 12, after which italso have a cysteine-rich C-terminal domain, as do ver-
tebrate VEGF-C and VEGF-D (Figure 4C; Lee et al., restricted to the tips of growing ganglionic branches
and more strongly in the visceral branches (Figures 5B,1996a), but lack the C-terminal heparin binding domain
Cell
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Figure 5. mRNA Expression of Vegf Genes
In situ hybridization showing pattern of Vegf17E (A–D) and Vegf27Ca (E–H) RNA expression at stages indicated.
(A) Vegf17E expression is detected in a caudal ectodermal patch (ce) and tracheal cells (tr). Salivary gland (sg) staining (not seen in this focal
plane) persists through stage 15 (see [I]–[L]).
(B) Vegf17E expression continues in same tissues.
(C) Expression has restricted to tracheal visceral branches (vb, boxed), Malpighian tubules (mt), and an ectodermal ring (er) at posterior.
(D) Expression persists in salivary gland, Malpighian tubules, and ectodermal ring.
(E) Vegf27Ca is expressed in caudal ectoderm (ce) in similar position as Vegf17E, developing hindgut (hg), foregut (fg, out of focal plane), and
ventral nerve cord (vnc).
(F) Hindgut expression is prominent, especially as Malpighian tubules bud from hindgut.
(G) Expression continues in Malpighian tubules and ventral nerve cord (boxed). There is variable expression in dorsal epidermis (not shown).
(H) In late embryos, expression persists in a foregut derivative and Malpighian tubules (out of focus).
(I–L) Schematized expression patterns of Vegf genes (light blue, Vegf17E; dark blue, Vegf27Ca and 27Cb; light and dark blue cross hatch, all
three genes). Vegf27Cb expression pattern is nearly identical to that of Vegf27Ca.
(M–U) Close-ups showing correlated expression of Vegf and Vegfr genes.
(M) Boxed area in (C) showing Vegf17E expression in tracheal visceral branches (vb).
(N) Same view of embryo probed for Vegfr. Vegfr-expressing cells cluster near Vegf17E-expressing cells.
(O) Boxed area in (G) showing Vegf27Ca expression in ventral nerve cord (bracket).
(P) Same view of embryo probed for Vegfr. Vegfr-expressing blood cells are seen along ventral nerve cord. Bar for (M)–(P) equals 10 m.
(Q) Dorsal view of tail of stage 10 embryo showing Vegf27Ca expression in caudal ectoderm (ce) and along ventral nerve cord. White dotted
line, tail margin.
(R) Same view of stage 11 embryo probed for Vegf17E showing expression in caudal ectoderm. Tracheal expression is also visible.
(S) Same view of stage 11 embryo probed for Vegfr. Vegfr-expressing blood cells are associated with sites of Vegf17E and Vegf27Ca expression
in caudal ectoderm and ventral nerve cord.
(T) Stage 12 embryo showing Vegf27Ca expression in hindgut (bracket).
(U) Same view of embryo probed for Vegfr. Vegfr-expressing blood cells cluster around hindgut. Bar (Q)–(U) equals 20 m.
5C, and 5M). The latter is the site where a novel popula- expression pattern (schematized in Figures 5I–5L), so
only one is shown (Figures 5E–5H). Beginning at stagetion of Vegfr-positive cells cluster in the embryo (Figure
5N). From stage 12 on, Vegf17E was expressed in Mal- 9 and into stage 11, the genes were expressed in caudal
ectoderm and developing hindgut, foregut, and ventralpighian tubules, and beginning at stage 13, in a posterior
ring of ectodermal cells (Figures 5C and 5D). nerve cord (Figures 5E and 5I). The hindgut (and subse-
quent Malpighian tubule) expression during stagesVegf27Ca and Vegf27Cb were also expressed along
blood cell migration routes. Both displayed the same 11–13 corresponds precisely to the position where blood
VEGF Control of Drosophila Blood Cell Migration
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cells cluster after entering the tail (Figures 5T and 5U). most blood cells were redirected to anteroventral posi-
tions on and around the foregut, the site of ectopicThere was also a striking correlation between the loca-
tion of Vegf27Ca/27Cb expression and Vegfr-expressing expression closest to where they originate (Figures 6L
and 6M). Similar experiments using btl-Gal4 and XPblood cells at the ventral nerve cord, along which hemo-
cytes move to reach the middle of the embryo (Figures d5686 (Figure 4B) to misexpress Vegf17E (Figure 6N)
did not show an effect on hemocyte migration (Figure5O, 5P, 5Q, and 5S). In late embryogenesis, Vegf27Ca/
27Cb expression was detected in Malpighian tubules 6O), nor did experiments using a UAS-Vegf17E trans-
genic line (UAS-Vegf17E-B; data not shown). This sug-and a foregut derivative (Figures 5H and 5L), both of
which are also associated with migrating hemocytes gests that the activity or diffusion properties of VEGF17E
ligands may differ from those of VEGF27Cb.(data not shown).
In aggregate, the expression pattern of the three Vegf
genes coincided with many blood cell migratory paths. VEGF Signaling Functions Independently
This correlation was especially clear at the entry site of Apoptotic Signals
into the tail and along the ventral midline, paths that During their developmental migrations, blood cells lo-
Vegfr hemocytes fail to engage. cate and engulf apoptotic cells (Tepass et al., 1994).
There is remarkable similarity between the hemocyte
migration route and the pattern of apoptosis in the em-Vegf Genes Are Redundantly Required for Blood
Cell Migration bryo (Abrams et al., 1993), and Vegf genes are expressed
in many of the zones of apoptosis (Figures 7A and 7D).To determine if Vegf genes are required for hemocyte
migration, we isolated Vegf17E and Vegf27Cb mutants. We examined the relationship between cell death and
VEGF control of hemocyte migration. In Df(3L)H99 mu-Three Vegf17E mutants were examined, including
Vegf17Eex3.6, a transcript null allele (Figure 4B). No blood tant embryos lacking grim, reaper, and hid and thus
blocking apoptosis, Vegf ligand expression (17E andcell migration defects were detected in any of the mu-
tants. We also characterized a piggyBac[w] insertion in 27Cb) and the developmental migration of hemocytes
were unaffected (Figures 7B and 7E and data not shown;Vegf27Cb, Vegf27Cbc6947 (Figure 4A). It is a homozygous
viable insertion five nucleotides downstream of the 5 Zhou et al., 1995). Also, there was little effect when
ectopic cell death was induced by X-irradiation (Figuressplice site of the fourth intron. This would likely disrupt
exon 4–5 splicing and prevent inclusion of C-terminal 7C and 7F). We also found that despite the profound
impairment in migration of Vegfrc2195 hemocytes, theycoding sequences. No hemocyte migration defects were
detected. were still able to find and engulf apoptotic cells, as
judged by their increased expression of CRQ (see above)The above results suggested that if Vegf ligands are
required for blood cell migration, they are likely to be and their greatly enlarged and vacuolated morphology
(Figure 7H), which distinguishes activated hemocytes (Fig-redundant. To test for redundancy, we used RNAi (Ken-
nerdell and Carthew, 1998) to inactivate multiple Vegf ure 7G; Tepass et al., 1994) from naive hemocytes (Fig-
ure 7I). Thus, despite their spatial coincidence, the VEGFgenes simultaneously (Figure 6). As a control, we first
demonstrated that inactivation of Vegfr by RNAi could pathway and apoptotic signals appear to function inde-
pendently in the control of hemocyte movement.phenocopy the blood cell migration defects in Vegfr
mutants. 59% of embryos (n  49) showed mild (class The only gene previously known to alter the develop-
mental migration of hemocytes is singleminded, a tran-I) to severe (class III) defects in hemocyte migration
(Figures 6B–6D and 6I), with 24% of affected embryos scription factor that controls ventral midline develop-
ment (Crews et al., 1988). In sim embryos, ventralshowing a severe phenotype similar to that observed in
null Vegfr mutants (Figure 6D). RNAi of either Vegf27Ca midline cells do not develop normally, and hemocytes
do not migrate along this tissue (Figures 7J and 7K; Zhouor Vegf27Cb alone had little effect above background,
and simultaneous RNAi of both Vegf27Ca and Vegf27Cb et al., 1995). Ventral midline expression of Vegf27Cb is
selectively eliminated in sim embryos (Figures 7L andhad only a moderate effect (Figure 6I). Simultaneous
inactivation of all three Vegf genes, however, resulted 7M). Thus, sim functions upstream of Vegf27Cb in con-
trol of blood cell migration in the nervous system.in a defect very similar to Vegfr inactivation: 71% of
injected animals showed blood cell migration defects
(Figures 6F–6I), with 14% of affected embryos showing Discussion
the extreme phenotype (Figure 6H). We conclude that
Vegf ligands are redundantly required for blood cell mi- We have characterized a Drosophila gene, stasis, which
gration, and they are required for the same function as encodes a VEGFR homolog, and shown that the gene
Vegfr. is expressed in developing blood cells and is essential
for their migration into and around the posterior of the
embryo. We have also characterized three genes encod-Ectopic Expression of a Vegf Ligand Can Reroute
Blood Cell Migration ing VEGF homologs and shown that they are expressed
along blood cell migration routes. They, too, are requiredWe used the Gal4/UAS system (Brand and Perrimon,
1993) to test if misexpression of a Vegf ligand could for blood cell migration into and around the posterior,
and ectopic expression of a ligand can reroute migrationalter hemocyte migration. Misexpression of Vegf27Cb
in the developing foregut, salivary duct, trachea, and to new positions. These results establish that the Dro-
sophila VEGF pathway plays a critical role in controllingmidline glia using breathless-Gal4 driver (btl-Gal4; Fig-
ures 6J and 6K) and UAS-Vegf27Cb (XP d2444; Figure developmental migrations of blood cells. While consid-
erable progress has been made in understanding the4A) caused misrouting of hemocytes. In many embryos,
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processes that guide blood cells to sites of infection
and inflammation in mammals (Butcher and Picker,
1996), our results begin to reveal the molecular pro-
cesses and pathways that guide developmental migra-
tions of blood cells. Remarkably, nearly all blood cell
movements in the posterior appear to be controlled by
the VEGF pathway. It is also notable that it is a VEGF
pathway, because vertebrate VEGF pathways are so
prominently associated with blood vessel development.
Below, we propose a molecular model by which the
VEGF pathway controls blood cell migration, discuss
its relationship to the pathways that control blood cell
homing on apoptotic cells, and explore evolutionary im-
plications.
Role of VEGF Signaling in Blood Cell Migration
Drosophila blood cells are born in the head and course
posteriorly between the yolk sac and amnioserosa to
reach the tail of the embryo. They then leave the amnio-
serosa and migrate toward the hindgut and ventral mid-
line, and from there they diverge along three pathways
toward the center of the embryo. Vegfr is one of the two
earliest specific hemocyte markers (Bernardoni et al.,
1997), and it is expressed throughout their migrations. In
Vegfr mutants, the initial posterior movements appear
normal, but they do not enter the tail and complete their
migrations. The site of migratory arrest coincides with
positions of Vegf expression; ligands are expressed in
the caudal ectoderm at the entry site (Vegf17E, Vegf27Ca,
and Vegf27Cb) and in the hindgut and along the ventral
midline (Vegf27Ca and Vegf27Cb), where blood cells
proceed once they enter the tail. Although inactivation
of individual ligand genes had little effect on hemocyte
migration, simultaneous inactivation of all three caused
the same hemocyte phenotype as Vegfr inactivation.
Thus, the Vegf genes are redundantly required for blood
cell movement into and around the posterior.
The results imply that the VEGF homologs serve as
ligands for the VEGFR homolog. First, the VEGF and
VEGFR homologs share significant sequence similarity
to their vertebrate counterparts in the functionally impor-
tant domains. No other Drosophila genes with compara-
Figure 6. Effect of Vegf Inactivation and Misexpression on Blood ble homology were identified. Second, ligand genes are
Cell Migration expressed near cells expressing the receptor gene, so
Embryos were injected with dsRNA to inactivate (RNAi) genes indi- the secreted ligands likely contact receptor-bearing
cated, allowed to develop, and immunostained for CRQ. Punctate
cells. Third, simultaneous inactivation of the three Vegfstaining is blood cells; diffuse staining is nonspecific background.
genes caused the same phenotype as inactivation of(A–H) Representative embryos of the four resultant phenotypic
the lone Vegfr gene, demonstrating they are required forclasses. Class 0, normal (evenly distributed blood cells); class I,
mild migration defect (blood cells biased to anterior, bracketed re- the same process. Finally, misexpression of Vegf27Cb
gion); class II, moderate migration defects (anterior bias plus some increased MAPK activation and altered migration of
blood cell clumping, arrowheads); and class III, severe blood cell Vegfr-expressing blood cells, demonstrating that local-
migration defects (strong anterior bias and extensive clumping simi-
ized expression of the ligand is critical. Although ourlar to amorphic Vegfr phenotype). Embryos in (A), (B), (E), and (F)
data do not exclude the possibility of coreceptors orare dorsal views.
(I) Bar graph showing percent of embryos with class I (open), II (gray
fill), and III (black fill) migration defects. Genes inactivated by RNAi
are indicated below each bar.
(J and K) Fluorescence micrographs of stage 13 (J) and 15 (K; dorsal to show lumens of foregut (arrow), salivary gland, hindgut, and tra-
view) btl-Gal4, UAS-GFP embryos to show expression pattern of cheae.
Gal4 driver. Driver is expressed in developing foregut (bracket and (N) In situ hybridization of stage 13 XP 5686 (UAS-Vegf17E)/; btl-
arrow) starting at stage 11, as well as trachea, midline glia, and Gal4/ embryo with Vegf17E probe. Note prominent misexpression
salivary ducts. in foregut (bracket) and tracheae.
(L and M) Stage 13 (L) and stage 15 (M) btl-Gal4/XP d2444 (UAS- (O) Stage 15 XP d5686/; btl-Gal4/ embryo immunostained for
Vegf27Cb) embryos stained for CRQ. Hemocytes (circled) are redi- CRQ. Hemocytes are dispersed as in wild-type; migration is not
rected to foregut (arrow). Embryo in (L) was also stained with TL-1 affected by misexpression of Vegf17E.
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Figure 7. VEGF Pathway and Apoptotic Sig-
nals in Blood Cell Migration
(A–C) Close-ups of hindgut region in stage
11/12 wild-type embryo (A), Df(3L)H99 mutant
that blocks cell death pathway (B), and
X-irradiated wild-type with increased cell
death (C). Embryos were stained with acridine
orange to visualize apoptotic cells (column
1), probed for Vegf27Cb RNA (column 2), or
stained with -CRQ to visualize hemocytes
(column 3). Dotted lines, tail margin.
(A) Wild-type embryos have normal develop-
mental cell death near hindgut (bracket),
where Vegf27Cb is expressed and hemo-
cytes migrate.
(B) In cell death mutant, acridine orange stain-
ing is absent, but Vegf27Cb expression and
hemocyte migration are not distinguishable
from wild-type (brackets).
(C) Irradiated embryos show excess apopto-
sis outside hindgut, but Vegf27Cb expression
and hemocyte migration are unaffected
(brackets). Bar for (A)–(C) equals 20 m.
(D–F) Close-ups of ventral nerve cord region
in stage 13/14 wild-type and mutant embryos
treated as above.
(D) Wild-type embryos show apoptosis,
Vegf27Cb expression, and hemocyte migra-
tion in developing nervous system (bracket).
(E and F) In cell death mutant (E) and irradi-
ated embryo with increased death (F),
Vegf27Cb expression and hemocyte migra-
tion are not grossly affected although
Vegf27Cb expression in F appears less orga-
nized. Bar in (F) for (D)–(F) equals 10 m.
(G–I) Close up of hemocytes (encircled)
stained with -CRQ in wild-type (G) and
Vegfrc2195 (H) and Df(3L)H99 (I) homozygotes.
Note increased CRQ staining and enlarged,
rounded, and vacuolated (arrowhead) mor-
phology in (G) and (H), characteristic of
phagocytically active hemocytes, in contrast
to small, quiescent hemocytes in (I). Bar in (I)
for (G)–(I) equals 5 m.
(J) Wild-type stage 13 embryo stained with
-CRQ. Hemocytes migrate on ventral nerve
cord (bracket).
(K) Same view of simH9 mutant. Hemocytes do not migrate on ventral nerve cord (asterisk), but show normal distribution elsewhere.
(L) Stage 13 wild-type embryo showing Vegf27Cb expression in ventral midline (bracket), hindgut where Malpighian tubules bud (arrowheads),
and foregut (arrow).
(M) Same view of simH9 mutant. Vegf27Cb is not expressed in ventral midline (asterisk) but is expressed normally elsewhere (arrowheads and
arrow).
signaling intermediaries, for discussion we assume that (Vegf27Cb) in the foregut caused rerouting of blood cells
to this tissue, demonstrating that localized expressionthe biochemical relationship between VEGF ligands and
receptors established in vertebrates (Ferrara, 1999) is of the ligand provides guidance information. Duchek et
al. (2001) propose a similar role for VEGF17E in borderalso true for the Drosophila homologs. Recent biochemi-
cal experiments validate this assumption for VEGF17E cell migration in the egg.
In the chemoattraction model, VEGFs guide most(Duchek et al., 2001).
The simplest model of how VEGF signaling controls blood cell migrations into and around the posterior. Be-
cause there are multiple sites of Vegf gene expression,blood cell migration is that VEGFs serve as chemoattrac-
tants for blood cells expressing VEGFR. Vertebrate the question arises as to how cells progress from one
VEGF source to another. What causes them to leave theVEGFs function in vitro as chemoattractants for leuko-
cytes and blood vessel enthothelial cells (see below), first source encountered? Perhaps ligand expression is
highly dynamic, turning off transiently after a blood celland the ligand-expressing cells in Drosophila are lo-
cated at the entry site to the tail and along most hemo- arrives, or perhaps a cell’s arrival triggers mechanisms
that selectively desensitize the cell to ligand producedcyte migratory routes in the posterior. Thus, they are
perfectly positioned to guide hemocytes along these from that source. The different ligand and receptor iso-
forms could also play a role if they have different func-routes. Not only are Vegf ligand genes required for mi-
gration, but ectopic expression of one of them tional properties, as our misexpression studies with
Cell
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Figure 8. Three Phases of Blood Cell Migration Defined by VEGF Pathway Mutations.
Red, Vegfr-expressing blood cells. Blue, Vegf ligand expression. For ease in visualization, only Vegf expression near posteriorly migrating
cells is shown.
Vegf27Cb and Vegf17E suggest (Figure 6). There also expression not obviously associated with blood cell mi-
gration.could be auxiliary factors that promote blood cell move-
ment away from one VEGF source and on to the next.
An alternative model is that VEGF signaling induces Dual Control of Blood Cell Migration by VEGFs
differentiation of blood cells. In this model, the develop- and Signals from Apoptotic Cells
mental migrations would serve not only to distribute A major function of hemocytes is to remove apoptotic
hemocytes in the body, but also to expose them to cells. This function begins in the embryo during their
different microenvironments that promote their matura- developmental migrations. Although the developmental
tion and differentiation, as in vertebrate blood cell devel- migration pathway neatly coincides with regions of the
opment. VEGF signaling would provide an inductive cue, embryo undergoing apoptosis, the expression of Vegf
the absence of which leads to developmental arrest genes and migration of hemocytes into these regions
and consequent failure to migrate into the posterior. occurred normally when cell death was prevented and
However, this could not be a complete block in hemo- when ectopic cell death was induced. We also observed
cyte development, as Vegfr hemocytes express at least that in the Vegfr mutant that blocks migration, blood
two blood cell markers (PXN and CRQ) and display mor- cells displayed a phagocytic morphology, indicating
phological and molecular features of activated hemo- they were nevertheless able to locate and engulf dying
cytes, implying their phagocytic function is intact. cells. The results imply that VEGF control of hemocyte
We prefer the chemoattraction model, because the migration is independent of the signals that govern hom-
differentiation model does not readily explain rerouting ing toward cell corpses; the VEGF pathway provides
of blood cells in the Vegf27Cb misexpression experi- global cues that guide hemocyte movement around the
ment. However, the two models are not mutually exclu- embryo, and a separate signaling pathway, presumably
sive: VEGF signaling could both attract blood cells into involving the CD36-like scavenger receptor CRQ (Franc
the posterior and induce their differentiation. One out- et al., 1996), provides local cues that allow hemocytes
come of differentiation could be to alter the cells such to locate dying cells nearby. We suspect the complex
that they now prefer to migrate to the next VEGF source. and dynamic pattern of expression of Vegf genes is not
controlled by physiological signals such as cell death
pathways, but rather by a hard-wired program that hasVEGF Pathway Mutants Divide Blood Cell
evolved to bring hemocytes to areas where they areMigration into Three Phases
needed, including regions of abundant developmentalThe Vegf expression patterns and loss of function phe-
cell death. This hard-wired program may include sim, anotype suggest that VEGF signaling controls many mi-
regulator of midline glial and neuronal cell fate, whichgrations of blood cells, particularly those in and around
is required for CNS expression of Vegf27Cb and migra-the posterior (Figure 8). But the results also imply
tion of hemocytes along the CNS.involvement of other signaling pathways before and
after their arrival at the posterior. In Vegfrembryos, the
initial migration of hemocytes to the caudal margin is What Was the Ancestral Function
of VEGF Pathways?unaffected. Anteriorly and ventrally directed migrations
during these stages also appear grossly normal. This The presence of VEGF and VEGFR homologs in Dro-
sophila prompts the question of what the function ofdefines an early, Vegf-independent phase of migration
(Phase I, Figure 8). Also, the late dispersal of hemocytes VEGF pathways was before the evolutionary divergence
of vertebrates and invertebrates. VEGF pathways wereis not associated with Vegf expression, defining another
Vegf-independent phase (Phase III). It will be important discovered and named in vertebrates because of their
effects on blood vessel endothelial cells (Keck et al.,to identify the pathways that control these early and late
migrations and learn how they are coordinated with the 1989; Leung et al., 1989), and genetic studies have asso-
ciated them with blood vessel and lymphatic develop-VEGF pathway. It will also be of interest to explore the
function of VEGF signaling in the few domains of Vegf ment (Clauss, 2000). Because Drosophila have an open
VEGF Control of Drosophila Blood Cell Migration
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(Samakovlis et al., 1996). Primary antisera were: anti-PXN (Nelson etcirculatory system lacking blood vessels, it was not ob-
al., 1994) and anti-CRQ (1:1000; Franc et al., 1996); tracheal markersvious what functions their VEGF pathways would serve.
mAb2A12 (1:5) and TL-1 (1:4000); mAbFMM5 against muscle myosinThe discovery that the primary embryonic function of
(1:8); mAb against FasII (1:8); and anti-dpERK (1:500; Sigma).
the Drosophila VEGF pathway is in blood cell migration In situ hybridization of whole-mount embryos was performed with
suggests that the function of the ancestral pathway may single-stranded digoxigenin-labeled RNA probes and AP immuno-
not have been in blood vessels but in blood cells, where chemistry (O’Neill and Bier, 1994). Templates for probe preparation
were cDNA clone #7f81 (Vegfr), LD37208 (Vegf17E), pVegf27Ca, andmammalian VEGF pathways are also known to function.
pVegf27Cb. Control probes for the antisense strand gave no specificMammalian VEGFRs are expressed on the monocyte-
signal.macrophage blood cell lineage, and VEGF family mem-
bers including VEGF-A and placental growth factor
RNA Interference
(PlGF) bind VEGFR1 on monocytes and function as che- RNAi was done as described (Kennerdell and Carthew, 1998). Tem-
moattractants for these cells in vitro (Clauss et al., 1990; plates for transcription were generated by PCR using these primers
Shen et al., 1993; Barleon et al., 1996). In this evolution- and PCR templates: 5CGGTCACATTGATAAAGACGGC, 5CGGAA
GAAGGTCACGATAGC, and Vegfr 7f81; 5TTGGTGTCCCCGAACAary scenario, VEGF pathways originally functioned in
ACAG, 5GCACAAATCCTTGCGATACGAC, and pEX-UAS-VEGF2blood cells, perhaps as chemoattractants guiding their
(UAS-VEGF17E-A); 5ATGTTGCGCCGAAAGTTG, 5TGGGCAGCTTmovements. Only later did they evolve roles in blood
GCAGCGACCTT, and pVegf27Ca; 5AACCACACGGAATGCGGATG,
vessel and lymphatic development. Indeed, given the 5GCACCCCAGGCTTTACACTTTATG, and pVegf27Cb. Primers also
intimate functional and developmental association of contained T7 promoter sequences at their 5 ends. dsRNA was
blood cells and blood vessels (Shalaby et al., 1995; Choi synthesized with T7 RNA Polymerase. dsRNA (5 M) was injected
into the ventral side (50% egg length) of stage 1–3 w1118 embryos.et al., 1998), it is possible that blood vessels evolved
When multiple dsRNAs were injected, the concentration of eachfrom blood cells.
was proportionately reduced to maintain total dsRNA at 5 M.
Injected embryos were aged at 18C until stage 15–17, fixed inExperimental Procedures
3.7% formaldehyde, devitellinized with methanol, and stained with
-CRQ. At least 300 embryos were injected for each dsRNA orStrains and Genetics
combination tested. Because incompletely fixed and devitellinizedVegfrc2195 (strain c02195), Vegfrc2859 (c02859), Vegfrc3211 (c03211),
embryos were not removed prior to staining, up to 45% of embryosVegf17Ec5589 (c05589), and Vegf27Cbc6947 (c06947) were generated
in each preparation stained poorly and could not be scored, so theyin a large-scale mutagenesis using a modified mini-w piggyBac
were excluded from analysis.transposon (S. Thibault et al., in preparation). XP d5686 (d05686)
and XP d2444 (d02444) were generated in a large-scale mutagenesis
with a mini-w transposon carrying Gal4 UAS adjacent to an out- Ectopic Expression
wardly directed minimal promoter near each transposon end for The Gal4/UAS system (Brand and Perrimon, 1993) was used with
Gal4-dependent expression of flanking sequences. Insertion sites btl-Gal4 (Shiga et al., 1996), or gcm-Gal4 (M. Paladi and U. Tepass,
were determined by inverse PCR and sequencing of flanking geno- personal communication), which expresses Gal4 in hemocytes until
mic DNA. Vegf17Eex3.6 was generated by mobilization of the P[w] stage 12. UAS responders were UAS-Dras1N17 (Lee et al., 1996b),
transposon in EP(X)1624 (Flybase). The extent of the deletion was XP d2444 (inserted 83 bp upstream of Vegf27Cb 5 most cDNA
determined by PCR of genomic DNA using primer pairs spanning the sequence), and XP d5686 (162 bp upstream of Vegf17E 5 most
Vegf17E locus. No transcript was detected by in situ hybridization. cDNA sequence). UAS-Vegf17E-B was constructed by cloning
Other strains used (see Flybase) were Df(2L)TE128-11, which re- Vegf17E-B cDNA (LD30334) into pUAST; a transformant on chromo-
moves cytologic region 28E4-7 to 29B2-C1; srpAS, a hemocyte-spe- some III was used. Embryos were collected at 29C and stained
cific allele (Rehorn et al., 1996); Df(3L)H99; simH9; drk	P2; sose46; and with -CRQ.
dshcSL20. w1118 was used as a wild-type control.
Cell Death Analysis
Molecular Biology Acridine orange staining and X-irradiation (800 rad) of w1118 em-
Sequences of Vegfr and Vegf cDNAs were assembled from EST bryos were done as described (Abrams et al., 1993). Approximately
sequence contigs derived from Drosophila cDNA libraries generated 1/4 of the embryos from Df(3L)H99/tm3 parents failed to stain with
from embryo, imaginal disc, adult head, and Schneider S2 cell RNA. acridine orange and displayed an inactive hemocyte morphology
Three apparent full-length embryonic cDNAs (5.7 kb) for Vegfr by anti-PXN staining, but expression of Vegf27Cb and Vegf17E was
were sequenced: 7f81 (splice form A, GenBank AY079184), 10G41 not distinguishable from wild-type.
(B, GenBank AY079187), and 4G21 (C, GenBank AY079185). An
apparent full-length 1.9 kb cDNA clone for Vegf17E splice form B Acknowledgments
(LD30334, BDGP) was sequenced (GenBank AY079186); it uses a
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